The global U.S. Digital Therapeutics Market is estimated to be valued at Us$ 2.80 Bn in 2023 and is expected to exhibit a CAGR Of 33. % over the forecast period 2023 To 2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
Digital therapeutics deliver evidence-based therapeutic interventions to patients that are driven by high-quality software programs to prevent, manage, or treat a medical disorder or disease. They incorporate advanced technology such as devices, sensors, and mobile applications to collect health data and provide personalized care.
Market key trends:
Cloud computing is driving the growth of digital therapeutics by providing cost-effective storage and handling of large amount of patient data. The cloud infrastructure allows easy sharing of data among different stakeholders like patients, physicians and caregivers. It facilitates seamless integration of digital therapeutics into healthcare systems. The remote accessibility and round-the-clock service offered by cloud platforms are fueling their adoption in digital therapeutics delivery.
Segment Analysis
The U.S. digital therapeutics market can be segmented based on application, product and sales channel. Based on application, the market is dominated by treatment/care-related applications that includes diabetes, CNS disorders, chronic respiratory diseases, musculoskeletal disorders, and cardiovascular diseases among others. Diabetes segment dominates the market owing to growing adoption of diabetes management apps and increasing prevalence of diabetes in the region.
Key Takeaways
The Global U.S. Digital Therapeutics Market Size is expected to witness high growth, exhibiting CAGR of 33% over the forecast period, due to increasing prevalence of chronic diseases and growing adoption of advanced digital healthcare solutions.
Regional analysis
Regionally, the western United States dominates the digital therapeutics market due to rapid technological adoption and significant investments in digital healthcare infrastructure by public and private players in the region. States like California exhibit the highest demand for digital therapeutics in the country.
Key players
Key players operating in the U.S. digital therapeutics market are 2Morrow Inc., ResMed, Pear Therapeutics, Omada Health Inc., Teladoc Health, Lark Technologies, Kaia Health, Fitbit, Cognoa Inc., and Akili Interactive Labs, among others. The market is highly competitive with these players introducing new innovative solutions to gain competitive advantage in the market.
